Pure Global

A Study to Evaluate the Relative Bioavailability of Ruxolitinib Extended Release (XR) Tablets Compared With Ruxolitinib Immediate Release (IR) Tablets Administered Orally in Healthy Participants. - Trial NCT06310304

Access comprehensive clinical trial information for NCT06310304 through Pure Global AI's free database. This Phase 1 trial is sponsored by Incyte Corporation and is currently Recruitment Completed. The study focuses on Healthy Participants. Target enrollment is 24 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06310304
Phase 1
Recruitment Completed
drug
Trial Details
ClinicalTrials.gov • NCT06310304
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
A Study to Evaluate the Relative Bioavailability of Ruxolitinib Extended Release (XR) Tablets Compared With Ruxolitinib Immediate Release (IR) Tablets Administered Orally in Healthy Participants.
Relative Bioavailability of Ruxolitinib XR Tablets Compared With Ruxolitinib IR Tablets Administered Orally in Healthy Participants

Study Focus

Healthy Participants

Ruxolitinib IR

Interventional

drug

Sponsor & Location

Incyte Corporation

Lincoln, United States of America

Timeline & Enrollment

Phase 1

Mar 26, 2024

May 15, 2024

24 participants

Primary Outcome

INCB018424 pharmacokinetic (PK) in Plasma

Summary

This study is conducted to determine the Relative Bioavailability of Ruxolitinib XR Tablets
 Compared With Ruxolitinib IR Tablets Administered Orally in Healthy Participants.

ICD-10 Classifications

Seeking and accepting physical, nutritional and chemical interventions known to be hazardous and harmful
Healthy person accompanying sick person
Routine general health check-up of sports teams
Obesity
Persons with potential health hazards related to communicable diseases

Data Source

ClinicalTrials.gov

NCT06310304

Non-Device Trial